VA/DoD CLINICAL PRACTICE GUIDELINE FOR OPIOID THERAPY FOR CHRONIC PAIN

DRAFT 3 - DO NOT DISTRIBUTE
VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain
55. Helmer DA, Chandler HK, Quigley KS, Blatt M, Teichman R, Lange G. Chronic widespread pain,
mental health, and physical role function in OEF/OIF veterans. Pain Med. Oct 2009;10(7):1174-
1182.
56. Vanderlip ER, Sullivan MD, Edlund MJ, et al. National study of discontinuation of long-term opioid
therapy among veterans. Pain. Dec 2014;155(12):2673-2679.
57. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid
therapy discontinuation rates from the TROUP study. J Gen Intern Med. Dec 2011;26(12):1450-
1457.
58. Zedler B, Xie L, Wang L, et al. Risk factors for serious prescription opioid-related toxicity or
overdose among Veterans Health Administration patients. Pain Med. Nov 2014;15(11):1911-1929.
59. Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and
opioid overdose-related deaths. JAMA. Apr 6 2011;305(13):1315-1321.
60. Harden RN. Chronic opioid therapy: Another reppraisal. APS Bulletin. 2002;12(1).
61. Im JJ, Shachter RD, Oliva EM, Henderson PT, Paik MC, Trafton JA. Association of care practices with
suicide attempts in US veterans prescribed opioid medications for chronic pain management. J
Gen Intern Med. Jul 2015;30(7):979-991.
62. Campbell G, Bruno R, Darke S, Degenhardt L. Associations of borderline personality with pain,
problems with medications and suicidality in a community sample of chronic non-cancer pain
patients prescribed opioids for pain. Gen Hosp Psychiatry. Sep-Oct 2015;37(5):434-440.
63. Merrill JO, Von Korff M, Banta-Green CJ, et al. Prescribed opioid difficulties, depression and opioid
dose among chronic opioid therapy patients. Gen Hosp Psychiatry. Nov-Dec 2012;34(6):581-587.
64. Davidson CL, Babson KA, Bonn-Miller MO, Souter T, Vannoy S. The impact of exercise on suicide
risk: Examining pathways through depression, PTSD, and sleep in an inpatient sample of veterans.
Suicide Life Threat Behav. Jun 2013;43(3):279-289.
65. Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and
high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. Mar 7 2012;307(9):940-947.
66. Turner BJ, Liang Y. Drug overdose in a retrospective cohort with non-cancer pain treated with
opioids, antidepressants, and/or sedative-hypnotics: Interactions with mental health disorders. J
Gen Intern Med. Aug 2015;30(8):1081-1096.
67. Peirce GL, Smith MJ, Abate MA, Halverson J. Doctor and pharmacy shopping for controlled
substances. Med Care. Jun 2012;50(6):494-500.
68. Andrews J, Guyatt G, Oxman AD, et al. Grade guidelines: 14. Going from evidence to
recommendations: The significance and presentation of recommendations. J Clin Epidemiol. Jul
2013;66(7):719-725.
69. Guyatt GH, Oxman AD, Kunz R, et al. Going from evidence to recommendations. BMJ. May 10
2008;336(7652):1049-1051.
70. Newberry SJ, Ahmadzai N, Motala A, et al. AHRQ methods for effective health care. Surveillance
and identification of signals for updating systematic reviews: Implementation and early experience.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013.
71. Guirguis-Blake J, Calonge N, Miller T, Siu A, Teutsch S, Whitlock E. Current processes of the U.S.
Preventive Services Task Force: Refining evidence-based recommendation development. Ann
Intern Med. Jul 17 2007;147(2):117-122.
72. The guidelines manual. London: National Institute for Health and Care Excellence;2012.
http://www.nice.org.uk/article/pmg6/resources/non-guidance-the-guidelines-manual-pdf.
73. Martinez Garcia L, McFarlane E, Barnes S, Sanabria AJ, Alonso-Coello P, Alderson P. Updated
recommendations: An assessment of NICE clinical guidelines. Implement Sci. 2014;9:72.
74. White CM, Ip S, McPheeters M, et al. AHRQ methods for effective health care using existing
systematic reviews to replace de novo processes in conducting comparative effectiveness reviews.
February 2017 Page 182 of 192